Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice. - Wikidata - awgldk - TriplyDB

Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.

Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.

http://www.wikidata.org/entity/Q42947929

about

Versatile role of heparanase in inflammation Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.Low molecular weight heparin relieves experimental colitis in mice by downregulating IL-1β and inhibiting syndecan-1 shedding in the intestinal mucosa.Heparan sulfate proteoglycans.Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma The endothelial glycocalyx in syndecan-1 deficient mice.A Proteoglycan-Like Molecule Offers Insights Into Ground Substance Changes During Holothurian Intestinal Regeneration Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.Molecular functions of syndecan-1 in disease.Heparanase in inflammation and inflammation-associated cancer.Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex.Decorin potentiates interferon-γ activity in a model of allergic inflammation.Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis The role for decorin in delayed-type hypersensitivity The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target.Alterations in Corneal Sensory Nerves During Homeostasis, Aging, and After Injury in Mice Lacking the Heparan Sulfate Proteoglycan Syndecan-1.Heparanase: From basic research to therapeutic applications in cancer and inflammation.Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice.Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.Side-by-Side Alterations in Glycocalyx Thickness and Perfused Microvascular Density During Acute Microcirculatory Alterations in Cardiac Surgery.Expression of heparan sulfate proteoglycans in murine models of experimental colitis.

P2860

Q33770777-04EC3A60-F8EB-4994-AB73-67B5E45E40ED Q34731730-F29D08AA-DD25-4F73-A835-7F65E0C5BADA Q34846405-71898CE2-DADF-4516-A72E-1AF20B3DF2BA Q35059448-7B695169-85AB-45ED-895F-486BEF1309B8 Q35719599-B5379D4E-A5DB-471F-889F-338422DA58BC Q36325314-0619120A-8FAF-4DDB-9087-B87FC6EE7111 Q36769963-A46E04C1-1012-40FF-B679-525DD11DB0E9 Q36954969-58B14C41-F924-4179-8D05-7588E3F4BA03 Q37539888-8A81FE58-3225-4C1B-AB2C-2785EFF90D98 Q37950202-9BD055F7-7094-4D2B-8FF7-C726C679F938 Q38080632-C5787EB7-86EF-4B1F-A087-21929C5696EB Q38574126-554BCCBC-BB78-49E7-A86B-C83BE887C267 Q38985052-6FE08865-34D9-4B9F-9AA9-6D54A0B97508 Q39144769-FEA95BB9-4749-4BD4-87D4-202B55ACD389 Q39216398-410C2394-5C48-4086-A5D1-4722839BFD1E Q39613141-C9886949-8924-47EE-B19B-11E1A92F56E6 Q40324623-F396B3CD-1BED-4970-BCB1-BC4EC132A120 Q41451822-3890854C-26A6-430B-9708-C38C39653C85 Q41504332-F83D0C12-E6B2-466C-AE45-1E31613A3B5E Q42004230-9DC40AD8-F32F-4826-AD09-E4B5CECD57A0 Q42280649-724AC9BA-604F-41B6-949D-16EFE9399928 Q42587945-D2B9D7FA-27B0-432B-B030-DFF41FA579CD Q42996743-B3AC1E2B-BBC4-4A21-93B6-738B6F99BBED Q47842891-04E9D077-F9CF-43BB-A57D-7BA9C97B790E Q52845977-0876DDA0-FD37-452A-9DF3-DC42FA219395 Q53253169-A96B2A7E-2F31-4CBD-A52E-1F801AFC06CD Q54344427-67FF5D0A-0896-48DB-A265-D9B51F0C3E6D

P2860

Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice.

http://www.wikidata.org/entity/Q42947929

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@en

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@nl

type

label

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@en

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@nl

prefLabel

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@en

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@nl

P1433

Q42947929-6A54A214-B3C5-4762-AEF5-8A1DD637EBF6

P1476

Q42947929-21D5A063-07B5-478D-A703-99940045D493

P2093

Q42947929-4BD73479-441A-429B-94F1-2CA3B245D8EB

Q42947929-50059692-C333-4F89-A07F-693467CF5A36

Q42947929-65C25C65-8122-404E-8B04-59203F655720

Q42947929-9A0CC68B-63D8-4263-8FFA-64B1D68DBB1B

Q42947929-A3430DEF-AF8A-4237-9DD3-C890AD313D13

Q42947929-C466358F-30A7-4BB3-BB3C-68F98424EC46

Q42947929-E662C073-0878-44C9-A3A9-BC6E19B6DC7B

P2860

Q42947929-1EC1EB9E-0733-4A61-8CF5-ACF1623C036D

Q42947929-26655704-9558-4647-B9CC-FFCBE840F0EE

Q42947929-3318A208-B8F6-4A23-9FD6-EFE6244176D8

Q42947929-352EEF71-6763-49C9-975B-AE6603B462AC

Q42947929-3859A7EE-1178-47AA-9D33-48B50DCCF903

Q42947929-43230244-9879-4DD1-97A7-726CD36F8247

Q42947929-4FAB96EE-B711-4CEB-9366-BE66D8AC4267

Q42947929-54AA6BA5-71D0-4607-A224-74377816BBAE

Q42947929-57ED0D31-1C4C-472C-97BC-F3ECD0FDFF48

Q42947929-614B0D42-DCD9-45C1-B087-B07916180B1B

P304

Q42947929-EA930B5A-53BA-403B-8D0C-774083151178

P31

Q42947929-C9E67B4D-5715-4CC0-B1D5-99F8EBB1785E

P356

Q42947929-1968C8C2-45F8-48F5-B9F3-B11D4A85F4F4

P407

Q42947929-6EEEBB5E-C018-4719-8454-93C4D8DB962E

P433

Q42947929-0E35E51A-43F4-4BF3-A47B-0DEE9F9C1975

P478

Q42947929-E3D8A2A3-3319-4CD3-B426-2A37C0123049

P50

Q42947929-3FAB7A47-C948-49B9-8365-BB9393261518

Q42947929-9F99F7BB-C27B-4328-B451-45F7D2706FE4

P577

Q42947929-84AD798E-0FE2-4799-B091-EEDDC1F49016

P5875

Q42947929-03004F22-B9B9-46C3-8152-CA9081F9CBEF

P698

Q42947929-91E19035-E28E-4032-83A1-B17A4A5DCC02

P932

Q42947929-44E694E9-5BC4-430D-AAB0-508A5CDECF1D

P356

AJPATH.2010.080639

P1433

The American Journal of Pathology

P1476

Enoxaparin improves the course ...... in syndecan-1-deficient mice.

@en

P2093

Andreas Luegering

http://www.w3.org/2001/XMLSchema#string

Ezeddin Salem Gassar

http://www.w3.org/2001/XMLSchema#string

Jan Heidemann

http://www.w3.org/2001/XMLSchema#string

Ludwig Kiesel

http://www.w3.org/2001/XMLSchema#string

Martin Floer

http://www.w3.org/2001/XMLSchema#string

Martin K Wild

http://www.w3.org/2001/XMLSchema#string

Torsten Kucharzik

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory bowel disease: clinical aspects and established and evolving therapies

Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7)

Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes

Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis

Functions of cell surface heparan sulfate proteoglycans

Heparan sulphate proteoglycans fine-tune mammalian physiology

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease.

P304

146-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.080639

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

Wolfram Domschke

P577

2009-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40685885

http://www.w3.org/2001/XMLSchema#string

P698

20008145

http://www.w3.org/2001/XMLSchema#string

P932

2797877

http://www.w3.org/2001/XMLSchema#string